Why the study?
MMP induction and TIMP reduction contribute to ischemia/reperfusion injury post-MI and LV remodeling, prompting development of hybrid dual isotope SPECT/CT to evaluate MMP activation and myocardial blood flow after intracoronary rTIMP-3 delivery.
Does intracoronary rTIMP-3 reduce MMP activation and improve myocardial blood flow and function in a pig model of ischemia/reperfusion injury?
RCT (n=14)
Randomly assigned
Does intracoronary rTIMP-3 reduce MMP activation and improve myocardial blood flow and function in a pig model of ischemia/reperfusion injury?
Absolute Event Rate: 2.22% vs 4.03%
p-value: p=0.03
A novel hybrid SPECT/CT imaging approach successfully quantified the reduction in MMP activation and improvement in myocardial blood flow following intracoronary rTIMP-3 delivery in a porcine model of ischemia/reperfusion injury.
Background: The induction of matrix metalloproteinases (MMPs) and reduction in tissue inhibitors of MMPs (TIMPs) plays a role in ischemia/reperfusion (I/R) injury post-myocardial infarction (MI) and subsequent left ventricular remodeling. We developed a hybrid dual isotope single-photon emission computed tomography/computed tomography approach for noninvasive evaluation of regional myocardial MMP activation with 99m Tc-RP805 and dynamic 201 Tl for determination of myocardial blood flow, to quantify the effects of intracoronary delivery of recombinant TIMP-3 (rTIMP-3) on I/R injury. Methods: Studies were performed in control pigs (n=5) and pigs following 90-minute balloon occlusion–induced ischemia/reperfusion (I/R) of left anterior descending artery (n=9). Before reperfusion, pigs with I/R were randomly assigned to intracoronary infusion of rTIMP-3 (1.0 mg/kg; n=5) or saline (n=4). Three days post-I/R, dual isotope imaging was performed with 99m Tc-RP805 and 201 Tl along with contrast cineCT to assess left ventricular function. Results: The ischemic to nonischemic ratio of 99m Tc-RP805 was significantly increased following I/R in saline group (4.03±1.40), and this ratio was significantly reduced with rTIMP-3 treatment (2.22±0.57; P =0.03). This reduction in MMP activity in the MI-rTIMP-3 treatment group was associated with an improvement in relative MI region myocardial blood flow compared with the MI-saline group and improved myocardial strain in the MI region. Conclusions: We have established a novel hybrid single-photon emission computed tomography/computed tomography imaging approach for the quantitative assessment of regional MMP activation, myocardial blood flow, and cardiac function post-I/R that can be used to evaluate therapeutic interventions such as intracoronary delivery of rTIMP-3 for reduction of I/R injury in the early phases of post-MI remodeling.
No takes yet. Share an insight, caveat, or question.
Thorn et al. (2019) conducted an RCT in Ischemia/reperfusion injury post-myocardial infarction (n=14). Recombinant TIMP-3 (rTIMP-3) vs. Saline was evaluated on Ischemic to nonischemic ratio of 99m Tc-RP805 (MMP activation) (p=0.03).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: